D. Fraser Steele
Research Subjects
Research Interests
D. Fraser Steele has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
John N. Staniforth
Pharmaceutical Technology Research Group, Department of Pharmacy and Pharmacology, University of Bath, Bath, BA2 7AY, United Kingdom
1 shared publication- Mike Tobyn
Bristol-Myers Squibb
1 shared publication - Roman V. Moiseev
Reading School of Pharmacy, University of Reading, Whiteknights, P.O. Box 224, Reading RG66AD, UK
1 shared publication Stephen Edge
Pharmaceutical Technology Research Group, Department of Pharmacy and Pharmacology, University of Bath, Bath, BA2 7AY, United Kingdom
1 shared publication- Vitaliy V. Khutoryanskiy
Reading School of Pharmacy, University of Reading, Whiteknights, PO Box 224, Reading, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 24 April 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (5) , 926
Polyaphron Formulations Stabilised with Different Water-Soluble Polymers for Ocular Drug Delivery
As drug delivery to the eye has evolved over the last decades, researchers have explored more effective treatments for ocular diseases. Despite this, delivering drugs to the cornea remains one of the most problematic issues in ophthalmology due to the poor permeability of the cornea and tear clearance mechanisms. In this study, four different types of polyaphron formulations are prepared with 10% poloxamer 188 (P188), 10% poly(2-ethyl-2-oxazoline), 1% polyquaternium 10, and 3% sodium carboxymethylcellulose solutions mixed with 1% Brij® L4 in a caprylic/capric triglycerides solution. Their physicochemical characteristics, rheological properties, and stability are assessed. Additionally, a polyaphron with 3% polyquaternium 10 was prepared for the assessment of ex vivo corneal retention along with four other polyaphrons. The best retention on the ex vivo cornea was displayed by the 3% polyquaternium 10-based formulation. The 10% poloxamer 188 along with 1% polyquaternium 10-based polyaphrons appeared to be the most stable among the four prepared formulations. A toxicological evaluation of these formulations was performed using a slug mucosal irritation test and bovine corneal opacity and permeability assay, with all four polyaphrons proving good biocompatibility with ocular tissues. The developed drug delivery systems demonstrated an excellent potential for ocular drug delivery.
- 24 April 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (5) , 926
Open AccessPolyaphron Formulations Stabilised with Different Water-Soluble Polymers for Ocular Drug Delivery
As drug delivery to the eye has evolved over the last decades, researchers have explored more effective treatments for ocular diseases. Despite this, delivering drugs to the cornea remains one of the most problematic issues in ophthalmology due to the poor permeability of the cornea and tear clearance mechanisms. In this study, four different types of polyaphron formulations are prepared with 10% poloxamer 188 (P188), 10% poly(2-ethyl-2-oxazoline), 1% polyquaternium 10, and 3% sodium carboxymethylcellulose solutions mixed with 1% Brij® L4 in a caprylic/capric triglycerides solution. Their physicochemical characteristics, rheological properties, and stability are assessed. Additionally, a polyaphron with 3% polyquaternium 10 was prepared for the assessment of ex vivo corneal retention along with four other polyaphrons. The best retention on the ex vivo cornea was displayed by the 3% polyquaternium 10-based formulation. The 10% poloxamer 188 along with 1% polyquaternium 10-based polyaphrons appeared to be the most stable among the four prepared formulations. A toxicological evaluation of these formulations was performed using a slug mucosal irritation test and bovine corneal opacity and permeability assay, with all four polyaphrons proving good biocompatibility with ocular tissues. The developed drug delivery systems demonstrated an excellent potential for ocular drug delivery.